Drug-free sustained remission or spontaneous remission by natural history in rheumatoid arthritis? An unsolved question: comment on the article of Ajeganova et al

被引：6
|
作者：
Zeidler, Henning [1 ]
机构：
[1] Hannover Med Sch, Dept Immunol & Rheumatol, Carl Neuberg Str 1, D-30625 Hannover, Germany
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2017年 / 76卷 / 07期
关键词：
CLASSIFICATION CRITERIA;
D O I：
10.1136/annrheumdis-2016-210887
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：1
相关论文
共 50 条
  • [41] On-drug and drug-free remission by baseline symptom duration: abatacept with methotrexate in patients with early rheumatoid arthritis (vol 38, pg 2225, 2018)
    Bykerk, Vivian P.
    Burmester, Gerd R.
    Combe, Bernard G.
    Furst, Daniel E.
    Huizinga, Tom W. J.
    Ahmad, Harris A.
    Emery, Paul
    RHEUMATOLOGY INTERNATIONAL, 2019, 39 (05) : 945 - 945
  • [42] Clinical contrasts with the American College of Rheumatology/European League Against Rheumatism provisional definitions of remission in rheumatoid arthritis for clinical trials: comment on the article by Felson et al
    Rotar, Ziga
    Praprotnik, Sonja
    Tomsic, Matija
    ARTHRITIS AND RHEUMATISM, 2011, 63 (11): : 3642 - 3643
  • [43] Response to: 'Comment on 'Sustained discontinuation of infliximab with a raising-dose strategy after obtaining remission in patients with rheumatoid arthritis: the RRRR study, a randomised controlled trial' by Tanaka et al' by Berkhout et al
    Tanaka, Yoshiya
    Oba, Koji
    Takeuchi, Tsutomu
    ANNALS OF THE RHEUMATIC DISEASES, 2021, 80 (11)
  • [44] Immunoglobulin free light chain levels and rituximab response in rheumatoid arthritis: Comment on the article by Sellam et al
    Tekstra, Janneke
    van Roon, Joel
    Kormelink, Tom Groot
    Redegeld, Frank
    ARTHRITIS AND RHEUMATISM, 2011, 63 (12): : 4034 - 4035
  • [45] No evidence of short-term impact of repeated BNT162b2 vaccination on rheumatoid arthritis homeostasis in drug-free remission
    Bozzalla Cassione, Emanuele
    Mansoubi, Mehrad
    Mazzucchelli, Iolanda
    Luvaro, Terenzj
    De Stefano, Ludovico
    Xoxi, Blerina
    Grignaschi, Silvia
    Bugatti, Serena
    Montecucco, Carlomaurizio
    Manzo, Antonio
    CLINICAL RHEUMATOLOGY, 2022, 41 (08) : 2605 - 2607
  • [46] No evidence of short-term impact of repeated BNT162b2 vaccination on rheumatoid arthritis homeostasis in drug-free remission
    Emanuele Bozzalla Cassione
    Mehrad Mansoubi
    Iolanda Mazzucchelli
    Terenzj Luvaro
    Ludovico De Stefano
    Blerina Xoxi
    Silvia Grignaschi
    Serena Bugatti
    Carlomaurizio Montecucco
    Antonio Manzo
    Clinical Rheumatology, 2022, 41 : 2605 - 2607
  • [47] Comment on 'Sustained discontinuation of infliximab with a raising-dose strategy after obtaining remission in patients with rheumatoid arthritis: the RRRR study, a randomised controlled trial' by Tanaka et al
    Berkhout, Lea C.
    l'Ami, Merel J.
    Wolbink, Gerrit Jan
    Rispens, Theo
    ANNALS OF THE RHEUMATIC DISEASES, 2021, 80 (11)
  • [48] Explorative analyses of protein biomarkers in patients with early rheumatoid arthritis achieving sustained drug-free remission after treatment with tocilizumab- or methotrexate-based strategies: from transcriptomics to proteomics
    Teitsma, X. M.
    Jacobs, J. W. G.
    Concepcion, A. N.
    Petho-Schramm, A.
    Borm, M. E. A.
    van Laar, J. M.
    Bijlsma, J. W. J.
    Lafeber, F. P. J. G.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2018, 36 (06) : 976 - 983
  • [49] Baseline metabolic profiles of early rheumatoid arthritis patients achieving sustained drug-free remission after initiating treat-to-target tocilizumab, methotrexate, or the combination: insights from systems biology
    Teitsma, Xavier M.
    Yang, Wei
    Jacobs, Johannes W. G.
    Petho-Schramm, Attila
    Borm, Michelle E. A.
    Harms, Amy C.
    Hankemeier, Thomas
    van Laar, Jacob M.
    Bijlsma, Johannes W. J.
    Lafeber, Floris P. J. G.
    ARTHRITIS RESEARCH & THERAPY, 2018, 20
  • [50] Baseline metabolic profiles of early rheumatoid arthritis patients achieving sustained drug-free remission after initiating treat-to-target tocilizumab, methotrexate, or the combination: insights from systems biology
    Xavier M Teitsma
    Wei Yang
    Johannes W G Jacobs
    Attila Pethö-Schramm
    Michelle E A Borm
    Amy C Harms
    Thomas Hankemeier
    Jacob M van Laar
    Johannes W J Bijlsma
    Floris P J G Lafeber
    Arthritis Research & Therapy, 20
12345